Qualitative assessment of knowledge, attitude and practice of oncologists about precision medicine in cancer patients- study from Lahore, Pakistan

被引:0
作者
Naaem, Rida [1 ]
Hashmi, Furqan Khurshid [2 ]
Yaqub, Sulaman [2 ]
Noor, Dzul Azri Mohamed [1 ]
机构
[1] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, Gelugor, Pulau Pinang, Malaysia
[2] Univ Punjab, Univ Coll Pharm, Allama Iqbal Campus, Lahore, Pakistan
来源
PLOS ONE | 2024年 / 19卷 / 04期
关键词
PHARMACOGENOMICS; PHARMACISTS; ADOPTION;
D O I
10.1371/journal.pone.0299010
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Precision medicine (PM) is in great progressive stages in the West and allows healthcare practitioners (HCPs) to give treatment according to the patient's genetic findings, physiological and environmental characteristics. PM is a relatively new treatment approach in Pakistan Therefore, it is important to investigate the level of awareness, attitude, and challenges faced by oncology physicians while practicing PM for various therapies, especially cancer treatment.Objectives The present study aims to explore the level of awareness, attitude, and practice of PM in Pakistan along with the challenges faced by the oncologists for the treatment of cancer using the PM approach.Methods Phenomenology-based qualitative approach was used. Face-to-face in-depth interviews were conducted using the purposive sampling approach among oncologists in Lahore, Pakistan. The data were analyzed using thematic content analysis to identify themes and sub-themes.Results Out of 14 physicians interviewed 11 were aware of PM. They were keen on training to hone their skills and agreed on providing PM. Oncologists believed PM was expensive and given to affluent patients only. Other impeding factors include cost, lack of knowledge, and drug unavailability.Conclusions Despite basic knowledge and will to practice, resource and cost constraints were marked as significant barriers. Additional training programs and inclusion into the curriculum may help to pave the way to PM implementation in the future. In addition, health authorities and policymakers need to ensure a cheaper PM treatment can be made available for all cancer patients.
引用
收藏
页数:15
相关论文
共 45 条
  • [11] Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Survey Comparison of Physicians and Patients
    Ciardiello, Fortunato
    Adams, Richard
    Tabernero, Josep
    Seufferlein, Thomas
    Taieb, Julien
    Moiseyenko, Vladimir
    Ma, Brigette
    Lopez, Gustavo
    Vansteenkiste, Johan F.
    Esser, Regina
    Tejpar, Sabine
    [J]. ONCOLOGIST, 2016, 21 (03) : 292 - 300
  • [12] Clarke V., 2015, 3rd ed. Qualitative psychology: A practical guide to research methods Sage Publications Ltd
  • [13] Ersek Jennifer L, 2018, Am Soc Clin Oncol Educ Book, V38, P188, DOI 10.1200/EDBK_200633
  • [14] Gameiro GR, 2018, CLINICS, V73
  • [15] Precision Medicine: From Science To Value
    Ginsburg, Geoffrey S.
    Phillips, Kathryn A.
    [J]. HEALTH AFFAIRS, 2018, 37 (05) : 694 - 701
  • [16] The Path to Personalized Medicine
    Hamburg, Margaret A.
    Collins, Francis S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (04) : 301 - 304
  • [17] Prospects and Challenges of Precision Medicine in Lower- and Middle-Income Countries: A Brief Overview
    Haque, Mainul
    Islam, Tariqul
    Sartelli, Massimo
    Abdullah, Adnan
    Dhingra, Sameer
    [J]. BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2020, 19 (01): : 32 - 47
  • [18] Implementing Precision Medicine in a Community Cancer Center to Impact Outcomes in Lung Cancer
    Hassen, E.
    Khomani, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1040 - S1040
  • [19] ALK Inhibitors in the Treatment of ALK Positive NSCLC
    Khan, Muhammad
    Lin, Jie
    Liao, Guixiang
    Tian, Yunhong
    Liang, Yingying
    Li, Rong
    Liu, Mengzhong
    Yuan, Yawei
    [J]. FRONTIERS IN ONCOLOGY, 2019, 8
  • [20] What is precision medicine?
    Koenig, Inke R.
    Fuchs, Oliver
    Hansen, Gesine
    von Mutius, Erika
    Kopp, Matthias V.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (04)